Aratana Therapeutics, Inc., Elanco Animal Health Incorporated - M&A Call Transcript
Good morning. My name is Amy, and I will be your conference operator today. At this time, I would like to welcome everyone to Elanco strategic investment update. (Operator Instructions) Jim Greffet, Head of Investor Relations, you may begin your conference.
Thanks, Amy. Good morning. Thank for joining us as we announced important strategic investments for Elanco. I'm Jim Greffet, Head of Investor Relation. Joining me are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; Aaron Schacht, Executive Vice President, Innovation, Regulatory and Business Development; and Katy Grissom from Investor Relations.
During this conference call, we anticipate making projections and forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. For example, our results may be affected by competitive developments, the timing and success of new product launches, regulatory and legal
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |